RSV vaccines score landmark FDA approvals
Nat Rev Drug Discov
.
2023 Jul;22(7):523-525.
doi: 10.1038/d41573-023-00085-x.
Author
Katie Kingwell
PMID:
37258651
DOI:
10.1038/d41573-023-00085-x
No abstract available
Publication types
News
MeSH terms
Drug Approval
Humans
Respiratory Syncytial Virus Vaccines*
United States
United States Food and Drug Administration
Substances
Respiratory Syncytial Virus Vaccines